![Organon & Co. logo](/logos/OGN.webp)
Organon & Co.
NYSE:OGN
Overview | Financials
Company Name | Organon & Co. |
Symbol | OGN |
Currency | USD |
Price | 20.49 |
Market Cap | 5,275,621,770 |
Dividend Yield | 5.25% |
52-week-range | 10.835 - 23.1 |
Industry | Drug Manufacturers—General |
Sector | Healthcare |
CEO | Mr. Kevin Ali |
Website | https://www.organon.com |
An error occurred while fetching data.
About Organon & Co.
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio consists of three immunology products, such
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD